×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 1: From the Source: FDA Policy Updates and Considerations
Session Chair(s)
Catherine Gray, PharmD
Director, Office of Prescription Drug Promotion, OMP, CDER
FDA, United States
Leaders from key medical product centers at FDA will address recent guidance activities, policy updates, the Duke-Margolis second annual Future of Prescription Drug Promotion and Digital Marketing meeting, and compliance considerations.
Learning Objective : - Recognize significant advertising and labeling concerns that each FDA medical product Center addresses
- Identify and apply key policy advancements in prescription drug advertising and promotion
-
Formulate compliant responses to address misinformation about a prescription medical product
Speaker(s)
Speaker
Catherine Gray, PharmD
FDA, United States
Director, Office of Prescription Drug Promotion, OMP, CDER
Speaker
Representative Invited
FDA, United States
Speaker
Representative Invited
FDA, United States
Speaker
Representative Invited
FDA, United States
Have an account?